Hiroki Ishibashi

Hiroki Ishibashi

Auto-generated profile, based on publicly available information

Hiroki Ishibashi

Department of Emergency Iizuka Hospital Iizuka City Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in The Journal of Medical Investigation
Verified
Journal Article
Open access
PDF file
YSYu Saito
Yu Saito
MSMitsuo Shimada
Mitsuo Shimada
TUTohru Utsunomiya
Tohru Utsunomiya
YMYuji Morine
Yuji Morine
SISatoru Imura
Satoru Imura
HIHiroki Ishibashi
Hiroki Ishibashi
A patient with hepatic epithelioid angiomyolipoma (Epi-AML) with arterioportal venous shunting, who was successfully treated by a laparoscopic left lateral sectionectomy, is presented herein. AML is an uncommon benign neoplasm of the liver. Tumors composed predominantly of epithelioid cells have been subcategorized into Epi-AML, and the treatment strategy for Epi-AML is currently undetermined. There are no reports describing Epi-AML with arterioportal venous shunting to date. An arterioportal venous shunting of the liver tumor was suggested to be one of the malignant signs of the liver tumor. It would be important to differentiate Epi-AML with arterioportal venous shunting from hepatocellular carcinoma and hypervascular metastatic tumors. Minimally invasive resection, such as laparoscopic hepatectomy, for patients having Epi-AML with arterioportal venous shunting may be recommended. J. Med. Invest. 60: 262-266, August, 2013

23 October 2017 in Hyperfine Interactions
Verified
Journal Article
Closed access
PDF file
MSMakoto Seto
Makoto Seto
RMRyo Masuda
Ryo Masuda
YKYasuhiro Kobayashi
Yasuhiro Kobayashi
SKShinji Kitao
Shinji Kitao
MKMasayuki Kurokuzu
Masayuki Kurokuzu
KMKo Mibu
Ko Mibu

12 March 2024 in Journal of General and Family Medicine
Verified
Journal Article
Open access
HIHiroki Ishibashi
Hiroki Ishibashi
RYRyo Yoshinaga
Ryo Yoshinaga
TYTetsuhisa Yamada
Tetsuhisa Yamada
Eppikajutsuto (EPTJ) is used to reduce redundant body fluids and suppress inflammation. We observed that EPTJ shortened the duration of treatment in an elderly patient with burn injuries. A 96-year-old man suffered superficial partial-thickness burns on the dorsum of his right hand and left knee. The injuries showed early improvement with the use of EPTJ. This suggests that EPTJ could contribute to shortening the duration of healing for superficial partial-thickness burns in elderly patients who may experience slow wound healing and have a high mortality rate. Eppikajutsuto needs to be considered as a treatment for burns in primary care. We observed that EPTJ shortened the duration of treatment in a 96-year-old man with superficial partial-thickness burn injuries. Eppikajutsuto needs to be considered as a treatment for burns in primary care.image